Search Results - "Schonsiegel, F"
-
1
Correction: The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
Published in Cell death & disease (29-01-2024)Get full text
Journal Article -
2
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
Published in Cell death & disease (01-05-2013)“…Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer stem cells (CSCs), which are not targeted by current therapies, may be…”
Get full text
Journal Article -
3
Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib
Published in Cell death & disease (16-10-2014)“…Giant cell tumor of bone (GCTB) is a very rare tumor entity, which is little examined owing to the lack of established cell lines and mouse models and the…”
Get full text
Journal Article -
4
Enrichment of c-Met super(+) tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib
Published in Cell death & disease (01-10-2014)“…Giant cell tumor of bone (GCTB) is a very rare tumor entity, which is little examined owing to the lack of established cell lines and mouse models and the…”
Get full text
Journal Article -
5
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3)
Published in European journal of nuclear medicine and molecular imaging (01-05-2003)“…Targeted transfer of a functionally active sodium iodide symporter (NIS) into tumour cells may be used for radioiodine therapy of cancer. Therefore, we…”
Get full text
Journal Article -
6
Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene
Published in Cancer gene therapy (01-01-2004)“…In order to achieve tumor-specific targeting of adeno-associated virus (AAV)-mediated gene expression, the promoter of the glucose transporter isoform 1…”
Get full text
Journal Article